USP30 has been reported to promote lipid accumulation and tumour progression by stabilising ACLY in hepatocellular carcinoma [20, 21], and the recruitment of USP30 stabilises DRP1 to promote hepatocarcinogenesis [20]. Here, USP30 is linked to neoplasm.